As of 2025-05-23, the Relative Valuation of Rapid Therapeutic Science Laboratories Inc (RTSL) is 0.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 USD, the upside of Rapid Therapeutic Science Laboratories Inc based on Relative Valuation is 378.3%.
The range of the Relative Valuation is 0.03 - 0.04 USD.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 6.1x | 5.2x |
| Forward P/E multiples | 4.4x - 6.1x | 5.2x |
| Fair Price | 0.03 - 0.04 | 0.04 |
| Upside | 302.7% - 454.0% | 378.3% |
| Date | P/E |
| 2025-05-05 | 1.10 |
| 2025-05-02 | 1.10 |
| 2025-04-28 | 1.10 |
| 2025-04-25 | 1.10 |
| 2025-04-24 | 1.10 |
| 2025-04-17 | 1.10 |
| 2025-04-16 | 1.10 |
| 2025-04-08 | 1.11 |
| 2025-04-07 | 1.11 |
| 2025-03-31 | 1.13 |
| 2025-03-06 | 0.74 |
| 2025-02-20 | 0.59 |
| 2025-02-12 | 0.59 |